Lantern Pharma Inc (NASDAQ: LTRN) on Friday, soared 3.73% from the previous trading day, before settling in for the closing price of $4.83. Within the past 52 weeks, LTRN’s price has moved between $2.79 and $11.99.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -30.27%. With a float of $8.03 million, this company’s outstanding shares have now reached $10.78 million.
Let’s determine the extent of company efficiency that accounts for 21 employees. In terms of profitability, gross margin is 63.75%, operating margin of -8120.0%, and the pretax margin is -7313.46%.
Lantern Pharma Inc (LTRN) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Lantern Pharma Inc is 25.49%, while institutional ownership is 11.98%. The most recent insider transaction that took place on May 24 ’24, was worth 126,600. In this transaction 10% Owner of this company sold 20,000 shares at a rate of $6.33, taking the stock ownership to the 57,467 shares. Before that another transaction happened on May 23 ’24, when Company’s 10% Owner sold 10,000 for $6.25, making the entire transaction worth $62,500. This insider now owns 59,326 shares in total.
Lantern Pharma Inc (LTRN) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -30.27% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.13% during the next five years compared to -39.81% drop over the previous five years of trading.
Lantern Pharma Inc (NASDAQ: LTRN) Trading Performance Indicators
Lantern Pharma Inc (LTRN) is currently performing well based on its current performance indicators. A quick ratio of 8.31 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.77, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -1.74 in one year’s time.
Technical Analysis of Lantern Pharma Inc (LTRN)
Looking closely at Lantern Pharma Inc (NASDAQ: LTRN), its last 5-days average volume was 79440.0, which is a drop from its year-to-date volume of 0.13 million. As of the previous 9 days, the stock’s Stochastic %D was 29.70%. Additionally, its Average True Range was 0.51.
During the past 100 days, Lantern Pharma Inc’s (LTRN) raw stochastic average was set at 66.71%, which indicates a significant increase from 49.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 62.36% in the past 14 days, which was lower than the 94.52% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.04, while its 200-day Moving Average is $4.27. However, in the short run, Lantern Pharma Inc’s stock first resistance to watch stands at $5.11. Second resistance stands at $5.22. The third major resistance level sits at $5.37. If the price goes on to break the first support level at $4.85, it is likely to go to the next support level at $4.70. Now, if the price goes above the second support level, the third support stands at $4.59.
Lantern Pharma Inc (NASDAQ: LTRN) Key Stats
Market capitalization of the company is 54.01 million based on 10,785K outstanding shares. Right now, sales total 0 K and income totals -15,960 K. The company made 0 K in profit during its latest quarter, and -4,510 K in sales during its previous quarter.
